Wilex updates IPO plans

Cancer company Wilex (Munich, Germany) said it will offer up to 4 million shares at EUR 13.80-EUR 15.80 in an IPO on the Frankfurt Stock Exchange. If the company sells 4 million shares at the midpoint of EUR 14.80, it would raise EUR 59.2 million ($75.3 million) and have a post-money valuation of EUR 177 million ($225.1 million). WestLB is sole lead manager and sole bookrunner, while Sal. Oppenheim is co-lead manager. The shares are expected to begin trading Nov. 13. ...